Qualio is a cloud-based quality management software system founded in 2012 and headquartered in the United States. With the slogan "Scalable, fast, and trusted eQMS software to make quality easy," Qualio targets various industries including Biotechnology, Health and Wellness, Life Sciences, Medical Devices, Pharmaceutical, and Productivity.
The company's Series B funding round on 25 May 2021 saw an investment of $50.00M from a consortium of prominent investors including Frontline Ventures, Sorenson Capital, Storm Ventures, Menlo Ventures, MHS Capital, Tiger Global Management, and Operator Partners.
Qualio's cloud-based platform caters specifically to life science companies, enabling them to achieve a more efficient route to market, increased revenues, and reduced risks. With a clientele of 650+ companies in 80 countries, Qualio supports the embedding and automation of GxP, FDA, and ISO compliance through the consolidation of teams, processes, and data into a centralized source of truth. This approach fosters a quality culture, ultimately strengthening and making businesses more competitive.
